Conmed (CNMD) Net Margin (2010 - 2026)
Conmed posted quarterly Net Margin of 4.36% for Q1 2026, up 248.0% year-on-year from 1.25% in Q1 2025, and down 2.76% on a QoQ basis from 4.49% in Q4 2025.
Conmed (CNMD) has 17 years of Net Margin data on file, last reported at 4.36% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 248.0% year-over-year to 4.36%; the trailing twelve-month figure through Mar 2026 stood at 4.0% (down 502.0% YoY), and the FY2025 full-year result was 3.42%, down 671.0% from the prior year.
- Net Margin for Q1 2026 stood at 4.36%, down from 4.49% in the prior quarter.
- Across five years, Net Margin topped out at 16.78% in Q3 2022 and bottomed at 60.71% in Q2 2022.
- The 5-year median for Net Margin is 6.18% (2022), against an average of 3.03%.
- The widest annual swing landed in 2022, when Net Margin tumbled 6592 bps; it then jumped 6504 bps in 2023.
- A 5-year view of Net Margin shows it stood at 10.6% in 2022, then declined by 5 bps to 10.11% in 2023, then declined by 4 bps to 9.76% in 2024, then sank by 54 bps to 4.49% in 2025, then retreated by 3 bps to 4.36% in 2026.
- The last three Net Margin figures came in at 4.36% (Q1 2026), 4.49% (Q4 2025), and 0.85% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn | 4.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.36% |
| Dec 31, 2025 | 4.49% |
| Sep 30, 2025 | 0.85% |
| Jun 30, 2025 | 6.26% |
| Mar 31, 2025 | 1.88% |
| Dec 31, 2024 | 9.76% |
| Sep 30, 2024 | 15.47% |
| Jun 30, 2024 | 9.03% |
| Mar 31, 2024 | 6.31% |
| Dec 31, 2023 | 10.11% |
| Sep 30, 2023 | 5.20% |
| Jun 30, 2023 | 4.32% |
| Mar 31, 2023 | 0.62% |
| Dec 31, 2022 | 10.60% |
| Sep 30, 2022 | 16.78% |
| Jun 30, 2022 | -60.71% |
| Mar 31, 2022 | 6.18% |
| Dec 31, 2021 | 8.92% |
| Sep 30, 2021 | 6.01% |
| Jun 30, 2021 | 5.21% |
| Mar 31, 2021 | 4.24% |
| Dec 31, 2020 | 9.55% |
| Sep 30, 2020 | 2.88% |
| Jun 30, 2020 | -17.37% |
| Mar 31, 2020 | 2.77% |
| Dec 31, 2019 | 5.64% |
| Sep 30, 2019 | 2.98% |
| Jun 30, 2019 | 2.39% |
| Mar 31, 2019 | 0.47% |
| Dec 31, 2018 | 6.46% |
| Sep 30, 2018 | 2.88% |
| Jun 30, 2018 | 4.10% |
| Mar 31, 2018 | 5.27% |
| Dec 31, 2017 | 20.98% |
| Sep 30, 2017 | 3.79% |
| Jun 30, 2017 | 3.11% |
| Mar 31, 2017 | -2.44% |
| Dec 31, 2016 | 3.29% |
| Sep 30, 2016 | 3.97% |
| Jun 30, 2016 | 1.49% |
| Mar 31, 2016 | -1.25% |
| Dec 31, 2015 | 4.11% |
| Sep 30, 2015 | 5.24% |
| Jun 30, 2015 | 4.12% |
| Mar 31, 2015 | 3.55% |
| Dec 31, 2014 | 5.81% |
| Sep 30, 2014 | 1.13% |
| Jun 30, 2014 | 5.45% |
| Mar 31, 2014 | 4.74% |
| Dec 31, 2013 | 5.03% |
| Sep 30, 2013 | 3.17% |
| Jun 30, 2013 | 4.94% |
| Mar 31, 2013 | 5.61% |
| Dec 31, 2012 | 5.41% |
| Sep 30, 2012 | 5.12% |
| Jun 30, 2012 | 5.43% |
| Mar 31, 2012 | 5.13% |
| Dec 31, 2011 | -13.54% |
| Sep 30, 2011 | 4.75% |
| Jun 30, 2011 | 4.74% |
| Mar 31, 2011 | 4.90% |
| Dec 31, 2010 | 3.78% |
| Sep 30, 2010 | 5.09% |
| Jun 30, 2010 | 4.03% |